Frontiers in Psychiatry is an interdisciplinary journal that focuses on translational and ‘bench-to-beside’ approaches to improve therapeutic options for mental illness and consequently to improve patient treatment outcomes.

Led by Field Chief Editor Prof Stefan Borgwardt (University of Lübeck, Germany), the journal publishes research across a wide spectrum of translational, basic, and clinical research in psychiatry, including all aspects of diagnosis, nature, causes, treatment, and public health aspects of mental illnesses.

The journal seeks submissions that communicate translational progress and innovations in all fields of psychiatry, including but not limited to:

ADHD
addictive disorders
adolescent and young adult psychiatry
aging psychiatry
anxiety and stress disorders
autism
behavioral and psychiatric genetics
computational psychiatry
digital mental health
forensic psychiatry
intellectual disabilities
mental health occupational therapy
molecular psychiatry
mood disorders
neuroimaging
neurostimulation
perinatal psychiatry
personality disorders
psychological therapy and psychosomatics
psychopathology
psychopharmacology
public mental health
schizophrenia
sleep disorders
social neuroscience
social psychiatry and psychiatric rehabilitation.

Studies on psychiatric diseases, predictive imaging and genomics, as well as computational modeling and novel biomarkers, which provide the foundations for the integrative bio-social context of public mental health, societal well-being and cutting-edge clinical practice and specialization are of particular interest. The journal actively welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being

Manuscripts that focus primarily on the physiological aspects of diseases, such as cancer or stroke, without a foundation in psychiatric or mental health issues are not suitable for publication in this journal. Similarly, studies that primarily investigate the physical effects of treatments, such as side effects or motor function, without a foundation in mental health are also not within the scope of this journal. Furthermore, research that is purely statistical or demographic in nature, without a foundation in psychiatric practice or theory, is not appropriate for this journal. General Commentary articles as well as Book Reviews are only accepted in Frontiers in Psychiatry upon invitation.

Frontiers in Psychiatry is committed to advancing the discovery and developments in the field by allowing unrestricted access to articles, and communicating scientific knowledge to researchers and the public alike.

Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as Mendelian Randomization or NHANES studies, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered.

Articles

The New and EmergIng PharmacologIC Treatments For MDD

Frontiers in Psychiatry

Psychopharmacology